Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Hedenfalk

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Oncogene|July 12, 2005
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cellsAsa Kronblad, Ingrid Hedenfalk, Elise Nilsson, et al.
Plos One|October 19, 2020
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patientsPia Leandersson, Anna Åkesson, Ingrid Hedenfalk, et al.
Genes, Chromosomes & Cancer|October 20, 2009
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiencyKarin Rennstam, Anita Ringberg, Heather E Cunliffe, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2011
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)Cecilia Nilsson, Marit Holmqvist, Leif Bergkvist, et al.
Cancers|January 15, 2021
Homologous Recombination Repair Mechanisms in Serous Endometrial CancerJenny-Maria Jönsson, Maria Bååth, Ida Björnheden, et al.
Cancer Research|November 4, 2005
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancersPontus Berglund, Maria Stighall, Karin Jirström, et al.
Genes, Chromosomes & Cancer|December 16, 2011
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosisIda Johansson, Kristina E Aaltonen, Anna Ebbesson, et al.
Molecular Oncology|November 30, 2013
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrencesSiker Kimbung, Anikó Kovács, Pär-Ola Bendahl, et al.
BMC Clinical Pathology|July 12, 2008
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairsSara Brommesson, Göran Jönsson, Carina Strand, et al.
Translational Oncology|October 27, 2015
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer SurvivalJenny-Maria Jönsson, Nicolai Skovbjerg Arildsen, Susanne Malander, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Oncogene|July 12, 2005
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cellsAsa Kronblad, Ingrid Hedenfalk, Elise Nilsson, et al.
Plos One|October 19, 2020
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patientsPia Leandersson, Anna Åkesson, Ingrid Hedenfalk, et al.
Genes, Chromosomes & Cancer|October 20, 2009
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiencyKarin Rennstam, Anita Ringberg, Heather E Cunliffe, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2011
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)Cecilia Nilsson, Marit Holmqvist, Leif Bergkvist, et al.
Cancers|January 15, 2021
Homologous Recombination Repair Mechanisms in Serous Endometrial CancerJenny-Maria Jönsson, Maria Bååth, Ida Björnheden, et al.
Cancer Research|November 4, 2005
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancersPontus Berglund, Maria Stighall, Karin Jirström, et al.
Genes, Chromosomes & Cancer|December 16, 2011
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosisIda Johansson, Kristina E Aaltonen, Anna Ebbesson, et al.
Molecular Oncology|November 30, 2013
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrencesSiker Kimbung, Anikó Kovács, Pär-Ola Bendahl, et al.
BMC Clinical Pathology|July 12, 2008
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairsSara Brommesson, Göran Jönsson, Carina Strand, et al.
Translational Oncology|October 27, 2015
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer SurvivalJenny-Maria Jönsson, Nicolai Skovbjerg Arildsen, Susanne Malander, et al.
Pageof 7